Cartalax
Also known as: Ala-Glu-Asp
Tripeptide cartilage bioregulator; modulates chondrocyte gene expression and supports cartilage matrix integrity.
- Typical dose
- 10 mcg
- Frequency
- once daily
- Route
- Subcutaneous
- Half-life
- 30 minutes
- Routes
- Subcutaneous
- Status
- Research chemical (Russian bioregulator)
Benefits
- Cartilage repair support
- Joint health
- Chondroprotective
- Anti-aging for joints
Dosing
A common research range for Cartalax is 10 mcg once daily. 10-day course; repeat every 3-6 months. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.
Reconstitution
A typical reconstitution for Cartalax is 1 mg of peptide in 1 mL of bacteriostatic water, giving roughly 1 mg per mL. Vial's built-in calculator works out the exact syringe draw for any vial size and dose.
Half-life
Cartalax has an approximate half-life of 30 minutes. Vial can display informational half-life estimates when supported data is available. These estimates are not measured blood concentrations or dosing instructions.
Storage
2-8°C.
Reported side effects
- Minimal reported
Contraindications
- Pregnancy
Commonly stacked with
Track Cartalax with Vial
Vial logs every Cartalax dose, organizes your schedule, and offers reconstitution math and supported half-life estimates. Tracking records stay on your device. A Vial Pro subscription is required. Download Vial on the App Store →
This page is for educational and harm-reduction purposes only. Cartalax is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.